Oncotarget is a research institute that publishes research papers in the oncology field and cancer research. The development of tumors and the complexity of the human body also encompasses papers being published in the immunology, physiology, endocrinology, pathology, and in the age-related disease fields.
Other fields that have relevance to the primary target research papers include aging issues, all pathology issues in addition to oncology, chromosome research, immunology, autophagy and diseases of the cells. Learn more about Oncotarget at Research Gate.
The editors-in-chief are Andrei V. Gudkov and Mikhail V. Blagosklonny. The frequency of publication has risen to two issues per week on Tuesday and Friday. This helps to get the highly important information out to those who value a timely content refresh so any gaps will be covered without delay.
Oncotarget adheres to the COPE Code of Conduct and the Guidelines of Best Practice for the Editors of Journals and Journal Publishers.
The editors of Oncotarget submissions base their evaluation strictly on the basis of their merit scientifically. There can be no importance of influence placed on the author’s race, citizenship, ethnic origin, gender, sexual orientation, political philosophy, or religious belief.
One of the core beliefs and principle relies upon a strict peer review system by experts in the field that is being presented in the manuscript. The experts that review the manuscripts are selected by the assistant editors of Oncotarget. The Editor-in-Chief will make the decision in regard to decisions as to whether or not the manuscript should be rejected or sent to the editors for review or revision.
If an article needs to be revised it is then sent back to the authors for revision or rebuttal The reviewers can initiate the review process no more than three times. Once a third time for revision is reached, the article must be revised and approved or it will be rejected. No papers have accepted that show any defamation, infringement of copyrights, falsification, fabrication of any kind, or plagiarism.
— Oncotarget (@OncotargetJrnl) December 5, 2017
Another vital process is that of peer review. Without a review of appropriate peers, the information in the documents has no real value as there is no other authority who can legitimately speak to the issues. Listen to an audio podcast of Oncotarget on Itunes.